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AbstrAct
Online application for survival analysis (OASIS) has served as a popular and 
convenient platform for the statistical analysis of various survival data, particularly 
in the field of aging research. With the recent advances in the fields of aging research 
that deal with complex survival data, we noticed a need for updates to the current 
version of OASIS. Here, we report OASIS 2 (http://sbi.postech.ac.kr/oasis2), which provides 
extended statistical tools for survival data and an enhanced user interface. In 
particular, OASIS 2 enables the statistical comparison of maximal lifespans, which is 
potentially useful for determining key factors that limit the lifespan of a population. 
Furthermore, OASIS 2 provides statistical and graphical tools that compare values in 
different conditions and times. That feature is useful for comparing age-associated 
changes in physiological activities, which can be used as indicators of “healthspan.” 
We believe that OASIS 2 will serve as a standard platform for survival analysis with 
advanced and user-friendly statistical tools for experimental biologists in the field of 
aging research.
IntroductIon
The amount of lifespan data is increasing due 
to rapid growth in the field of aging research. Hence, 
proper statistical analysis for dissecting the genetic and 
environmental factors associated with aging has become 
more crucial than ever before. We previously reported 
OASIS, a web service for survival analysis [1]. OASIS 
has become a popular online platform for experimental 
biologists in the field of aging research who need 
convenient access to statistical tools for the analysis of 
survival data including lifespan. After 5 years of extensive 
OASIS usage, it has become apparent that more features 
are required for the analysis of complex phenomena 
involved in aging. Here, we report OASIS 2, which 
provides crucial updated features including advanced 
statistical analysis and an enhanced user-friendly interface.
results
OASIS 2 has a new feature for the proper 
quantification of differences in maximal lifespan between 
datasets. The maximal lifespan is the upper percentile of 
the lifespan distribution, which contrasts with the mean 
lifespan [2]. The maximal lifespan is determined by 
the “fundamental process of aging,” whereas the mean 
lifespan changes with various conditions such as diseases. 
This is of interest, because increasing the maximal 
lifespan can imply that an intervention is slowing the 
general processes of aging and not merely retarding the 
development of specific diseases [3]. Hence, it could be 
useful to detect differences in maximal lifespan as opposed 
to simply the “curve squaring” that can be induced by 
increasing the mean or median lifespan without increasing 
the maximal lifespan [4].
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Using the maximal lifespan analysis implemented in 
OASIS 2, we tested Caenorhabditis elegans lifespan data 
that have different maximal lifespan values (Materials and 
Methods). Worms overexpressing fat-6, which encodes 
delta(9)-fatty-acid desaturase, had a mean lifespan 
similar to that of wild-type worms but had a shorter 
maximal lifespan (Figure 1A). The log-rank test that was 
implemented in our previous version of OASIS showed 
that the difference between the wild-type and transgenic 
animals was not statistically significant (P = 0.057; Figure 
1D). In contrast, Boschloo’s test, which is implemented 
in OASIS 2 as well as in SurvCurv [5] and examines the 
differences in the proportion of longevity outliers that 
live beyond specific time points, detected a significant 
difference in maximal lifespan between the wild-type and 
transgenic animals (P = 0.029; Figure 1D). In addition, a 
Mann-Whitney U test, as modified by Gao and Allison [6], 
which was newly implemented in OASIS 2, showed that 
the difference in maximal lifespan was highly significant 
(P = 9.0×10-4; Figure 1D). The modified Mann-Whitney 
U test was able to determine the differences in the 
distribution tails of survival data affecting the maximal 
lifespan as well as the differences in the proportions of 
longevity outliers. To the best of our knowledge, OASIS 
2 is the only web service that provides such functionality.
We also analyzed other lifespan datasets taken 
from different conditions and model organisms. For 
example, worms treated with an RNAi targeting daf-16, 
FOXO transcription factor, had shorter mean lifespan and 
maximal lifespan than wild-type worms (Figure 1B) [7]. 
A log-rank test, Boschloo’s test, and the modified Mann-
Whitney U test indicate that the differences in the mean 
and maximal lifespans are significant (P = 0 in the Log-
rank test, P = 7.6×10-8 in Boschloo’s test, P = 1.2×10-14 
in the Mann-Whitney U test; Figure 1D). We re-analyzed 
mouse lifespan data that had similar maximal lifespan 
values [8]. Female mice had a maximal lifespan similar to 
that of male mice but had a longer mean lifespan (Figure 
1C). A log-rank test indicates that the difference in mean 
lifespan values is significant (P = 8.0×10-4; Figure 1D); 
however, the Boschloo’s test and the modified Mann-
Whitney U test show that the difference in maximal 
lifespan values is not significant (P = 0.329 in the Mann-
Whitney U test; P = 0.41 in Boschloo’s test; Figure 1D). 
We also validated the statistics by comparing the results 
to those of (a) SurvCurv, which provides comparisons of 
Figure 1: Analysis of maximal lifespans using oAsIs 2 survival plots of A. wild-type and fat-6-overexpressing C. elegans, b. 
wild-type and daf-16 RNAi-treated C. elegans [7], and c. female and male wild-type mice visualized using OASIS 2 [8]. d. Shown are the 
conceptual figures of three statistical tests. The P-values of each statistical test are shown. 
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maximum lifespans, and (b) JMP and STATA, which are 
well-known statistical packages. We confirmed that the 
OASIS 2 results are the same as the results obtained by 
SurvCurv, JMP, or STATA. We provide the comparison of 
those statistical data as well as the raw data on the OASIS 
2 website (http://sbi.postech.ac.kr/oasis2/benchmark). 
Overall, OASIS 2 provides analytical methods that are 
suitable for calculating the statistical significance of 
survival data focused on maximal lifespan.
OASIS 2 also provides statistical tools and graphical 
outputs for the comparison of values in multiple groups 
factored by condition and time, which are useful for 
analyzing differences in physiological activities depending 
on conditions and times. To demonstrate those features of 
OASIS 2, we re-analyzed data regarding the movement 
capacity of C. elegans worms of different ages, which 
we recently published [9]. Wild-type animals displayed 
declines in movement capacity during aging, which 
was accelerated by glucose-rich diets (Figure 2A). We 
implemented a two-way ANOVA that compares values in 
multiple groups factored by condition and time (Materials 
and Methods; Figure 2B). By using the ANOVA, we 
were able to show a significant difference in movement 
capacity between the control and glucose-treated animals 
(P = 3.1×10-12, Source of variation: Conditions; Figure 
2B). We also showed a significant difference in movement 
capacity among worms of different ages (P = 3.5×10-70, 
Source of variation: Time). Furthermore, we showed that 
the effect of the glucose treatment depends on the age of 
the worm (P = 9.0×10-4, Source of variation: Interaction). 
For an additional exploration of the pair-wise differences 
among the means of multiple groups, we also performed 
a post hoc analysis implemented in OASIS 2 (Figure 2C).
OASIS 2 has an interface that generates graphical 
outputs for many kinds of changes in values (e.g., 
physiological activities) in multiple groups factored by 
Figure 2: Analysis of differences in physiological values factored by time and conditions using oAsIs 2 A. Time-
dependent changes in motilities of control and glucose-fed populations of wild-type C. elegans. b. Shown are conceptual figures of two-
way ANOVA for testing differences in physiological-activity values among different times or conditions. Degrees of freedom (df) and the 
results of F-tests (F-value, P-value, and F-critical value) are displayed according to the sources of variation. c. Shown are the results of a 
post hoc analysis calculated by OASIS 2. Tukey’s honest significant difference is used to calculate the P-value. d. Input for the analysis of 
physiological values.
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Figure 3: Features of the enhanced user-friendly interface of oAsIs 2. A. Exporting options for data analysis in OASIS 2. Data 
filters are applied to the contents of both the output records and the exported data. b. Interactive charting of survival curves. Modified charts 
can be exported to various formats. Detailed data information can be highlighted as a popup when a mouse pointer hovers. The display of 
sample curves can be switched by clicking chart legends. c. OASIS 2 displayed in a smartphone (left) and a tablet-PC (right). d. User-
friendly updates. Panel I: data submission page. The checkbox for drawing mortality plots is provided in the “Graphs” section. Panel II: 
output page. Counts of censored data are displayed in the results of a Kaplan-Meier estimation. Linear interpolation is added to the columns 
of the “Mean/Median Lifespan” section.
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conditions and times. The input data have a structured 
format that includes at least three columns: time and two 
conditions including a treatment and a control (Figure 2D). 
The columns should be divided with tabs. The users need 
to record the physiological activities of specific numbers 
of individuals from selected populations, which are in 
specific conditions and at specific time points (e.g., age). 
OASIS 2 gives a more user-friendly interface than 
the previous version. It enables the users to export the 
results of statistical analyses in various formats, in contrast 
to the previous version, which displayed the results only 
in HTML documents (Figure 3A). Moreover, users of 
OASIS 2 can customize the export options by choosing 
the combinations of columns in various formats. An 
interactive charting ability enables the users to compare 
survival curves more conveniently (Figure 3B). The 
interactive charts can be exported as modifiable vector 
images, such as Scalable Vector Graphics (SVG) and 
Portable Document Format (PDF) files, enabling users to 
easily obtain publication-quality figures. In addition, we 
updated the OASIS 2 webpage to follow the common web 
standards. Hence, users can operate OASIS 2 with tablets 
or smartphones as well as with personal computers (Figure 
3C). OASIS 2 also works smoothly with various internet 
browsers including Microsoft Internet Explorer 11 and 
Edge, Google Chrome, and Apple Safari on Windows and 
Mac OS X.
We also updated OASIS 2 to adapt to the needs of 
experimental biologists (Figure 3D). Users can analyze 
survival data not only on a daily basis but also on an 
hourly one, because OASIS 2 now supports numbers with 
decimal points for time inputs. For example, 20.5 days 
indicates 20 days and 12 hours. Other features updated 
for user convenience include (1) mortality-rate plotting, 
(2) linear interpolation of the mortality curve, and (3) the 
counting of censored data. For researchers who need to 
analyze security-sensitive data, such as data related to 
the Health Insurance Portability and Accountability Act, 
OASIS 2 has two features to ensure data security. First, 
analyzed data can be accessed only by those with the IP 
addresses of the data uploaders. Second, the uploaded data 
are automatically discarded after 10 days.
OASIS 2 also provides several weighted log-rank 
tests that can be used for various statistical tests. OASIS 2 
now supports the Wilcoxon-Breslow-Gehan test, Tarone-
Ware’s test, and the Peto-Peto-Prentice test as well as 
Fleming-Harrington’s test (Figure 3D). We also validated 
those statistical tests and confirmed that the results 
of OASIS 2 are same as the results obtained from the 
statistical package STATA (http://sbi.postech.ac.kr/oasis2/
benchmark#wlogrank).
dIscussIon
Recently, web-based tools such as OASIS and 
SurvCurv have emerged as convenient analysis tools for 
survival data. In this paper, we report on the new features 
of OASIS 2, which provides advanced statistical tools and 
an enhanced user interface. OASIS 2 provides features 
such as the statistical comparison of maximal lifespan. It 
has recently emerged that physiological changes with age 
have been used to measure healthspan in model animals as 
well as in humans [10, 11]. Thus, the analysis pipeline for 
values in multiple groups factored by condition and time 
can provide useful tools for the analysis of healthspan, 
which relies on the analysis of changes in physiological 
activities during aging. We believe that OASIS 2 will help 
experimental biologists to easily conduct various statistical 
analyses associated with the complex phenomena of aging.
MAterIAls And Methods
C. elegans data set
Lifespan assays were performed as described 
previously [12]. Briefly, wild-type (N2) and fat-6-
overexpressing worms (IJ508 yhEx112 [ges-1p::fat-
6::GFP, odr-1::RFP]) were maintained on Escherichia 
coli (OP50)-seeded nematode growth medium (NGM) 
agar plates at 20°C. Synchronized wild-type and fat-6-
overexpressing animals were transferred onto OP50-
seeded NGM agar plates containing 10 μM 5-fluoro-2’-
deoxyuridine (FUdR, Sigma, St Louis, MO, USA) at day 
1 adult stage to prevent progeny from hatching. Worms 
that did not respond to gentle touching by a platinum wire 
were counted as dead. Animals that crawled off the plates, 
ruptured, or burrowed were censored but included in the 
statistical analysis. The movement-capacity data were 
adopted from our previously published paper [9].
statistical analysis of maximal lifespan 
comparison
Modifications of Boschloo’s Test and the Mann-
Whitney U Test were adopted to implement the 
comparisons of maximal lifespans in OASIS 2. The 
modifications of each test were designed by Gao-
Allison and Wang-Allison, respectively [6, 13]. The null 
hypothesis of Boschloo’s test (H
0,A
) is that the fraction of 
outliers that live beyond specific time points is similar 
between populations A and B. The equation of H
0,A 
is:
where x is an observation from the population, L(x) 
is the survival time of x, and t denotes some threshold 
chosen by the investigator, which could represent the 
criteria for a specific time point. We used the 90th 
percentile threshold as t. Boschloo’s test is applied to 
compare the fractions of outliers. The null hypothesis 
of the Mann-Whitney U test (H
0,AB
) is the compound of 
H
0,A
 and another null hypothesis (H
0,B
). H
0,B
 is that the 
Oncotarget56152www.impactjournals.com/oncotarget
outliers have a similar average survival time between two 
different populations. The equation of the compound null 
hypothesis (H
0,AB 
) is:
where I(o) is an indicator function taking on a value 
of 1 if o is true and a value of 0 otherwise. The Mann-
Whitney U test is applied to compare the average (μ) of Z 
variables between two populations.
statistical comparison of physiological activity
ANOVA is used to analyze differences in 
physiological activities depending on condition and time. 
Among different conditions, the mean values should 
change if the values are affected by the conditions over 
time. Therefore, the null hypothesis of the test (H0) is 
that the means of all samples are equal regardless of the 
variation in conditions. The equation of H0 is:
,
where μ
1
, ..., μk are the means of each condition. The 
H0 is rejected when at least one pair of means is not equal. 
To test the H0, the F-test is used. The F-value is calculated 
from the following formula:
where MS is the mean square, SS is the sum of 
squares, k is the number of conditions, and n is the number 
of samples within each condition. Finally, the P-value is 
estimated from the F-distributions.
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